Gapping up
In reaction to earnings/guidance:
- VSCO +9.1%, CRM +8.8%, WB +5%, CAE +4.1%, CPRI +2.9%, CONN +2.3%, HPQ +0.5%
Other news:
- NVGS +4.9% (names Mads Peter Zacho as CEO)
- LPI +4% (authorized $200 mln share repurchase program)
- AXSM +3.1% (Late-Breaking Presentations of Positive Results of the EVOLVE Trial of AXS-05)
- BITF +2.5% (reports May production)
- KYMR +2.3% (to Present Pre-clinical Data at the EULAR 2022 Congress Showing STAT3 Degradation Blocked Th17 Development and Prevented Rheumatoid Arthritis )
- LI +2.2% (May deliveries)
- KSCP +2.1% (deployed a K5 Autonomous Security Robot in a California park)
- DQ +2.1% (approves $120 mln share repurchase program)
- MCRB +1.9% (Presents Microbiome Therapeutic Research at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting)
- LICY +1.8% (Li-Cycle and Glencore enter into long-term commercial agreements and close Glencore $200 million investment in Li-Cycle)
- PTVE +1.7% (appointed Jonathan Baksht as CFO)
- NIO +1.6% (May deliveries)
- SIX +1.5% (appointed Gary Mick as CFO)
- XPEV +1.5% (May deliveries)
- GIAC +1.4% (agreed to combine with Freightos)
- THR +1.1% (acquired Powerblanket)
- EVEX +1% (partners with Porsche Consulting to define eVTOL global manufacturing logistics and supply chain strategy)
Analyst comments:
- ENTA +2.7% (upgraded to In-line from Underperform at Evercore ISI)
- PK +2.4% (upgraded to Buy from Hold at Truist)
- BPMC +1.9% (upgraded to Buy from Hold at Jefferies)
- DHR +1% (upgraded to Outperform from Sector Perform at RBC Capital Mkts)
- XYL +1% (upgraded to Outperform from Market Perform at Cowen)